The status of measles elimination in the United States (U.S.).
Prime Medicine shrinks CRISPR ambitions and gets cash infusion from Bristol Myers Squibb
Prime Medicine, founded with gene editing tech from the lab of star Harvard biochemist David Liu and backed by blue chip investors, made little secret